Division of Internal Medicine 2 (University Hospital Krems)

Projects

Projects per year 2016 2020 2022 2024 2027

• 6 Active
• 12 Finished

Projects per year

Search results

• Active

  ATEOL-LA : Prevalence, costs, and impact of anticancer treatment and Palliative Care Services at the end of life of patients with advanced lung cancer in Lower Austria

  Kreye, G. (PI)

  Forschungsimpulse

  01.11.2024 → 31.10.2026

  Project: Forschungsimpulse › Research Time Out (RTO)

• Investigating the role of MIC-A and MIC-B on tumor cells

  Singer, J. (PI)

  Forschungsimpulse

  01.03.2024 → 28.02.2025

  Project: Forschungsimpulse › Seed Funding

• Fight Cancer: Unraveling the pathogenesis to improve treatment of cancer metastasis

  Vallet, S. (PI)

  Forschungsimpulse

  01.03.2024 → 28.02.2027

  Project: Forschungsimpulse › Research Time Out (RTO)

• Breast Cancer: Uncovering new checkpoints in natural killer cells to prevent breast cancer metastasis

  Witalisz-Siepracka, A. (PI), Vallet, S. (CoPI) & Gotthardt, D. (CoPI)

  Gesellschaft für Forschungsförderung NÖ

  01.12.2022 → 30.11.2025

  Project: Funded Research

• JAK2 inhibitors: JAK2 inhibitors and the innate immune response in mutant CALR-driven MPNs

  Stoiber-Sakaguchi, D. (PI), Podar, K. (CoPI) & Kollmann, K. (CoPI)

  Gesellschaft für Forschungsförderung NÖ

  01.01.2022 → 31.12.2025

  Project: Funded Research

• APOG: ACCESS POINT Oncology

  Podar, K. (PI), Stoiber-Sakaguchi, D. (CoPI), Pecherstorfer, M. (CoPI), Georg, P. (CoPI), Kieseberg, P. (CoPI), Fossati, P. (CoPI), Lütgendorf-Caucig, C. (CoPI) & Slade, D. (CoPI)

  Land Niederösterreich

  01.01.2020 → 31.12.2026

  Project: Funded Research

• Finished

  Retrospektive Analyse der Inzidenz und der Kosten medikamentöser Antitumortherapie (Chemotherapie, „Small Molecules“, zielgerichtete Antikörpertherapie, Immuncheckpoint-Inhibitoren) in der letzten Lebensphase bei PatientInnen mit soliden Tumoren in Krems

  Kreye, G. (PI)

  Forschungsimpulse

  01.04.2022 → 31.03.2024

  Project: Forschungsimpulse › Seed Funding

  • Cancer Treatment 100%
  • Malignant Neoplasm 60%
  • Quality of Life 40%
  • Chemotherapy 40%
  • Salicylate Sodium 20%

• Evaluierung des Gesamtüberlebens sowie der Einbindung von Palliativ Care bei PatientInnen mit fortgeschrittenem nicht kleinzelligem Bronchialkarzinom im Stadium IV seit 2008 am Universitätsklinikum Krems

  Kreye, G. (PI)

  Forschungsimpulse

  01.04.2022 → 31.03.2024

  Project: Forschungsimpulse › Seed Funding

  • Symptomatic Treatment 100%
  • Small Cell Lung Cancer 100%
  • Patient Referral 18%
  • Oncology 12%
  • Overall Survival 12%

• Red flags: Red flags: Improving knowledge of serious pathologies

  Pecherstorfer, M. (CoPI), Wieser, M. (CoPI), Rausch, F. G. (CoPI) & Janssen, J. (PI)

  Gesellschaft für Forschungsförderung NÖ

  01.01.2022 → 31.12.2024

  Project: Funded Research

• Untersuchung der Effekte von Immun-Checkpoint Inhibitoren auf den Knochenumbau.

  Vallet, S. (PI)

  Forschungsimpulse

  01.11.2021 → 30.11.2023

  Project: Forschungsimpulse › Seed Funding

  • Clinical Study 100%
  • Bone Remodeling 100%
  • Ex Vivo 100%
  • Osteoplasty 100%
  • Programmed Death 1 Ligand 1 100%

• STAT3: STAT3 isoforms in hematopoietic disorders

  Stoiber-Sakaguchi, D. (PI), Podar, K. (CoPI) & Casanova, E. (CoPI)

  Gesellschaft für Forschungsförderung NÖ

  01.01.2021 → 31.12.2024

  Project: Funded Research

• PROTACs : Targeting Transcription factors for cancer therapy utilizing PROteolysis-TArgeting Chimera (PROTACs)

  Podar, K. (PI)

  Forschungsimpulse

  01.08.2020 → 31.10.2022

  Project: Forschungsimpulse › Research Time Out (RTO)

  • Multiple Myeloma 100%
  • Trametinib 66%
  • Cyclin-Dependent Kinase 44%
  • Immunoglobulin Producing Cell 44%
  • CRISPR 44%

• BONE: Biomarker- based therapeutic prevention of bone metastases in breast cancer: Defining the pathophysiologic impact of the endosteal niche

  Vallet, S. (PI)

  Forschungsimpulse

  01.08.2020 → 31.12.2023

  Project: Forschungsimpulse › Research Time Out (RTO)

  • Prospective Cohort Study 100%
  • Azacitidine 100%
  • Bone Remodeling 68%
  • Cisplatin 52%
  • Multiple Myeloma 50%

• Vertragsprüfung der klinischen Studie: Single Arm Phase II-Study in Patients with extensive stage small-cell lung cancer (ES-SCLC) with poor performance Staus receiving Atezolizumab-Carboplatin-Etoposide

  Zwickl-Traxler, E. (PI)

  Forschungsimpulse

  01.02.2020 → 31.07.2020

  Project: Forschungsimpulse › Seed Funding

• Biomarker: Biomarker- based therapeutic prevention of bone metastases in breast cancer. Defining the pathophysiologic impact of the endosteal niche

  Vallet, S. (PI), Podar, K. (CoI) & Wiesner, C. (CoPI)

  Gesellschaft für Forschungsförderung NÖ

  01.12.2019 → 31.12.2023

  Project: Funded Research

• Functional analysis of JunB-mediated immunosuppression

  Podar, K. (PI)

  Forschungsimpulse

  01.10.2019 → 30.09.2020

  Project: Forschungsimpulse › Seed Funding

  • Protein Kinase Inhibitor 100%
  • Multiple Myeloma 100%
  • Angiogenesis 100%
  • Angiogenic Factor 25%
  • Myeloma Cell 25%

• JunB in multiple myeloma

  Podar, K. (PI), Vallet, S. (CoI), Lind, J. (CoI), Czernilofsky, F. (CoI), Kollmann, K. (CoPI) & Hundsberger, H. (CoPI)

  Land Niederösterreich

  01.10.2018 → 30.09.2022

  Project: Funded Research

• Tumor Cachexia

  Pecherstorfer, M. (PI), Zwickl, H. (CoI), Eger, A. (CoPI), Gerner, C. (CoPI), Köfeler, H. (CoPI), König, F. (CoPI) & Ludvik, B. (CoPI)

  Gesellschaft für Forschungsförderung NÖ

  01.02.2016 → 31.07.2020

  Project: Funded Research